2

Feb 21

Asepsis Announces the Grant of U.S. Patent 10,857,299 for the Multi-Dose Safe-2-Dose® Syringe

Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose®...
Read More

21

May 20

Asepsis Announces the U.S. Patent Grant No. 10,625,026 for its Autogenic Momentum Injection Device.

Asepsis Medical Technologies announces the U.S. Patent Grant for the Momenta-Dose™ forcé actuated injection device. The Momenta Dose™ is designed to administer...
Read More

22

Feb 19

Asepsis Announces the Safe-2-Dose™ Integrated Dosing Container

Asepsis announces the patent pending Safe-2-Dose™, the next generation liquid medication dispenser. The caregiver need only unlock the device and...
Read More

6

Feb 19

Asepsis Announces Australian Patent Acceptance No. 2018232988 for its Multi-Indicia Infants’ and Children’s Oral Medication Dosing Applicator Comprising a Medication Paired Keyed End.

Asepsis Medical Technologies announces the Australian Patent Acceptance No.  2018232988 for a suction and/or pressure inducing oral medication dosing applicator.  The applicator...
Read More

2

Aug 18

Asepsis announces the USPTO Notice of Allowance for its second Patent Application for the Safe-T-Fuse™ specialty drug infusion system.

Asepsis Medical Technologies announces the USPTO issuance of Patent Application Number 15/255,725 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an...
Read More
1 2 3